189 related articles for article (PubMed ID: 34143952)
41. ALG12-CDG: An unusual patient without intellectual disability and facial dysmorphism, and with a novel variant.
de la Morena-Barrio ME; Sabater M; de la Morena-Barrio B; Ruhaak RL; Miñano A; Padilla J; Toderici M; Roldán V; Gimeno JR; Vicente V; Corral J
Mol Genet Genomic Med; 2020 Aug; 8(8):e1304. PubMed ID: 32530140
[TBL] [Abstract][Full Text] [Related]
42. ALG13 X-linked intellectual disability: New variants, glycosylation analysis, and expanded phenotypes.
Alsharhan H; He M; Edmondson AC; Daniel EJP; Chen J; Donald T; Bakhtiari S; Amor DJ; Jones EA; Vassallo G; Vincent M; Cogné B; Deb W; Werners AH; Jin SC; Bilguvar K; Christodoulou J; Webster RI; Yearwood KR; Ng BG; Freeze HH; Kruer MC; Li D; Raymond KM; Bhoj EJ; Sobering AK
J Inherit Metab Dis; 2021 Jul; 44(4):1001-1012. PubMed ID: 33734437
[TBL] [Abstract][Full Text] [Related]
43. Active site variants in STT3A cause a dominant type I congenital disorder of glycosylation with neuromusculoskeletal findings.
Wilson MP; Garanto A; Pinto E Vairo F; Ng BG; Ranatunga WK; Ventouratou M; Baerenfaenger M; Huijben K; Thiel C; Ashikov A; Keldermans L; Souche E; Vuillaumier-Barrot S; Dupré T; Michelakakis H; Fiumara A; Pitt J; White SM; Lim SC; Gallacher L; Peters H; Rymen D; Witters P; Ribes A; Morales-Romero B; Rodríguez-Palmero A; Ballhausen D; de Lonlay P; Barone R; Janssen MCH; Jaeken J; Freeze HH; Matthijs G; Morava E; Lefeber DJ
Am J Hum Genet; 2021 Nov; 108(11):2130-2144. PubMed ID: 34653363
[TBL] [Abstract][Full Text] [Related]
44. TRAPPC9-CDG: A novel congenital disorder of glycosylation with dysmorphic features and intellectual disability.
Radenkovic S; Martinelli D; Zhang Y; Preston GJ; Maiorana A; Terracciano A; Dentici ML; Pisaneschi E; Novelli A; Ranatunga W; Ligezka AN; Ghesquière B; Deyle DR; Kozicz T; Pinto E Vairo F; Witters P; Morava E
Genet Med; 2022 Apr; 24(4):894-904. PubMed ID: 35042660
[TBL] [Abstract][Full Text] [Related]
45. Increased Clinical Sensitivity and Specificity of Plasma Protein
Chen J; Li X; Edmondson A; Meyers GD; Izumi K; Ackermann AM; Morava E; Ficicioglu C; Bennett MJ; He M
Clin Chem; 2019 May; 65(5):653-663. PubMed ID: 30770376
[TBL] [Abstract][Full Text] [Related]
46. Human OS-9, a lectin required for glycoprotein endoplasmic reticulum-associated degradation, recognizes mannose-trimmed N-glycans.
Hosokawa N; Kamiya Y; Kamiya D; Kato K; Nagata K
J Biol Chem; 2009 Jun; 284(25):17061-17068. PubMed ID: 19346256
[TBL] [Abstract][Full Text] [Related]
47. The Role of Lectin-Carbohydrate Interactions in the Regulation of ER-Associated Protein Degradation.
Słomińska-Wojewódzka M; Sandvig K
Molecules; 2015 May; 20(6):9816-46. PubMed ID: 26023941
[TBL] [Abstract][Full Text] [Related]
48. Degradation of a short-lived glycoprotein from the lumen of the endoplasmic reticulum: the role of N-linked glycans and the unfolded protein response.
de Virgilio M; Kitzmüller C; Schwaiger E; Klein M; Kreibich G; Ivessa NE
Mol Biol Cell; 1999 Dec; 10(12):4059-73. PubMed ID: 10588643
[TBL] [Abstract][Full Text] [Related]
49. Mutations in COG2 encoding a subunit of the conserved oligomeric golgi complex cause a congenital disorder of glycosylation.
Kodera H; Ando N; Yuasa I; Wada Y; Tsurusaki Y; Nakashima M; Miyake N; Saitoh S; Matsumoto N; Saitsu H
Clin Genet; 2015 May; 87(5):455-60. PubMed ID: 24784932
[TBL] [Abstract][Full Text] [Related]
50. Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy.
Yang AC; Ng BG; Moore SA; Rush J; Waechter CJ; Raymond KM; Willer T; Campbell KP; Freeze HH; Mehta L
Mol Genet Metab; 2013 Nov; 110(3):345-351. PubMed ID: 23856421
[TBL] [Abstract][Full Text] [Related]
51. Biallelic variants in SLC35C1 as a cause of isolated short stature with intellectual disability.
Knapp KM; Luu R; Baerenfaenger M; Zijlstra F; Wessels HJCT; Jenkins D; Lefeber DJ; Neas K; Bicknell LS
J Hum Genet; 2020 Sep; 65(9):743-750. PubMed ID: 32313197
[TBL] [Abstract][Full Text] [Related]
52. Monoallelic and bi-allelic variants in NCDN cause neurodevelopmental delay, intellectual disability, and epilepsy.
Fatima A; Hoeber J; Schuster J; Koshimizu E; Maya-Gonzalez C; Keren B; Mignot C; Akram T; Ali Z; Miyatake S; Tanigawa J; Koike T; Kato M; Murakami Y; Abdullah U; Ali MA; Fadoul R; Laan L; Castillejo-López C; Liik M; Jin Z; Birnir B; Matsumoto N; Baig SM; Klar J; Dahl N
Am J Hum Genet; 2021 Apr; 108(4):739-748. PubMed ID: 33711248
[TBL] [Abstract][Full Text] [Related]
53. Mosaicism of the UDP-Galactose transporter SLC35A2 in a female causing a congenital disorder of glycosylation: a case report.
Westenfield K; Sarafoglou K; Speltz LC; Pierpont EI; Steyermark J; Nascene D; Bower M; Pierpont ME
BMC Med Genet; 2018 Jun; 19(1):100. PubMed ID: 29907092
[TBL] [Abstract][Full Text] [Related]
54. DDOST mutations identified by whole-exome sequencing are implicated in congenital disorders of glycosylation.
Jones MA; Ng BG; Bhide S; Chin E; Rhodenizer D; He P; Losfeld ME; He M; Raymond K; Berry G; Freeze HH; Hegde MR
Am J Hum Genet; 2012 Feb; 90(2):363-8. PubMed ID: 22305527
[TBL] [Abstract][Full Text] [Related]
55. Novel congenital disorder of O-linked glycosylation caused by GALNT2 loss of function.
Zilmer M; Edmondson AC; Khetarpal SA; Alesi V; Zaki MS; Rostasy K; Madsen CG; Lepri FR; Sinibaldi L; Cusmai R; Novelli A; Issa MY; Fenger CD; Abou Jamra R; Reutter H; Briuglia S; Agolini E; Hansen L; Petäjä-Repo UE; Hintze J; Raymond KM; Liedtke K; Stanley V; Musaev D; Gleeson JG; Vitali C; O'Brien WT; Gardella E; Rubboli G; Rader DJ; Schjoldager KT; Møller RS
Brain; 2020 Apr; 143(4):1114-1126. PubMed ID: 32293671
[TBL] [Abstract][Full Text] [Related]
56. Molecular diagnostic testing for congenital disorders of glycosylation (CDG): detection rate for single gene testing and next generation sequencing panel testing.
Jones MA; Rhodenizer D; da Silva C; Huff IJ; Keong L; Bean LJ; Coffee B; Collins C; Tanner AK; He M; Hegde MR
Mol Genet Metab; 2013; 110(1-2):78-85. PubMed ID: 23806237
[TBL] [Abstract][Full Text] [Related]
57. Novel ALG12 variants and hydronephrosis in siblings with impaired N-glycosylation.
Hiraide T; Wada Y; Matsubayashi T; Kadoya M; Masunaga Y; Ohkubo Y; Nakashima M; Okamoto N; Ogata T; Saitsu H
Brain Dev; 2021 Oct; 43(9):945-951. PubMed ID: 34092405
[TBL] [Abstract][Full Text] [Related]
58. ALG3-CDG (CDG-Id): clinical, biochemical and molecular findings in two siblings.
Riess S; Reddihough DS; Howell KB; Dagia C; Jaeken J; Matthijs G; Yaplito-Lee J
Mol Genet Metab; 2013; 110(1-2):170-5. PubMed ID: 23791010
[TBL] [Abstract][Full Text] [Related]
59. Congenital disorders of glycosylation with multiorgan disruption and immune dysregulation caused by compound heterozygous variants in MAN2B2.
Fan S; Wu H; Wang R; Chen Q; Zhang X
Mol Genet Genomic Med; 2024 Apr; 12(4):e2422. PubMed ID: 38622837
[TBL] [Abstract][Full Text] [Related]
60. EDEM1's mannosidase-like domain binds ERAD client proteins in a redox-sensitive manner and possesses catalytic activity.
Lamriben L; Oster ME; Tamura T; Tian W; Yang Z; Clausen H; Hebert DN
J Biol Chem; 2018 Sep; 293(36):13932-13945. PubMed ID: 30021839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
